$633 MillionThe market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.
$3.27 - $7.58The lowest and highst price in the last 52 weeks.
0.0xThe price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.
$0.00 (0.0%)Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).
|Market Cap||$633 Million|
|Dividend Yield||$0.00 (0.0%)|
|1 Year Return||+74.4%|
|Outstanding Shares||103 Million|
|Avg 30 Day Volume||1.07 Million|
|Earnings per Share||$0.00|
|Price to Sales Ratio||-|
|Price to Book Ratio||-|
|Revenue to Enterprise Value||-|
|EBIT to Enterprise Value||-|
|Total Debt to Enterprise Value||-|
|Debt to Equity||-|
|Quarterly Earnings Growth (YoY)||-|
|Return on Equity||-|
|Return on Assets||-|
|Return on Invested Capital||-|
140,963 shares sold (2 transactions)
CEO: Patrick McEnany
Industry: Pharmaceutical Preparation Manufacturing
Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX) shares, rose in value on Wednesday, 11/24/21, with the stock price up by 1.10% to the previous days close as stro...Stocks Register, about 2 months ago
Brokerages expect that Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) will report earnings of $0.11 per share for the current quarter, Zacks Investment Researc...Dakota Financial News, 2 months ago
Wall Street analysts expect that Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) will announce earnings per share (EPS) of $0.11 for the current quarter, accord...Transcript Daily, 2 months ago
Man Group plc trimmed its stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) by 16.0% during the 2nd quarter, according to the company in its most recent ...Dakota Financial News, 2 months ago